Pfizer, Inc. v. Apotex, Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
MICHEL, Chief Judge.
Pfizer Inc. filed suit against Apotex, Inc. (formerly known as TorPharm, Inc.) in the United States District Court for the Northern District of Illinois on July 30, 2003, alleging that, pursuant to 21 U.S.C. § 355(j)(5)(B)(iii), Apotex’s filing with the United States Food and Drug Administration (“FDA”) of its Abbreviated New Drug Application (“ANDA”) No. 76-719 seeking approval to commercially sell amlodipine besylate tablets (2.5 mg, 5 mg, and 10 mg strengths) before the expiration of the term of U.S. Patent No. 4,879,303 (“the '303 patent”) to Pfizer, infringed claims…
2Cases cited49 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Addington v. TexasSupreme Court of the United States · 1979
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
44 more not listed; retrieve them via the Exa API.
3Cited by274 opinions
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
- Activevideo Networks, Inc. v. Verizon Communications, Inc.Court of Appeals for the Federal Circuit · 2012
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
- Pharmasterm Therapeutics, Inc. v. Viacell, Inc.Court of Appeals for the Federal Circuit · 2007
- Voda v. Cordis Corp.Court of Appeals for the Federal Circuit · 2008
269 more not listed; retrieve them via the Exa API.